1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Piazza, M.
Futrega, K.
Spratt, D.E.
Guillemette, J.G.
Dieckmann, T.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
51
3651
3661
10.1021/bi300327z
22486744
Structure and Dynamics of Calmodulin (CaM) Bound to Nitric Oxide Synthase Peptides: Effects of a Phosphomimetic CaM Mutation.
2012
10.2210/pdb2ll7/pdb
pdb_00002ll7
16721.350
Calmodulin
1
man
polymer
1838.195
Nitric oxide synthase, endothelial
1.14.13.39
Calmodulin-binding region residues 493-509
1
man
polymer
CaM
Constitutive NOS, cNOS, EC-NOS, Endothelial NOS, eNOS, NOS type III, NOSIII
no
no
ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTD
SEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK
ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTD
SEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK
A
polypeptide(L)
no
no
KKTFKEVANAVKISASL
KKTFKEVANAVKISASL
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
sample
CALM1, CALM, CAM, CAM1, CALM2, CAM2, CAMB, CALM3, CALML2, CAM3, CAMC, CAMIII
9606
Homo sapiens
562
Escherichia coli
pET9dCaM
human
sample
NOS3
9606
Homo sapiens
562
Escherichia coli
database_2
pdbx_database_status
repository
Initial release
Database references
Other
1
0
2012-05-16
1
1
2023-06-14
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.status_code_nmr_data
BMRB
Y
RCSB
2011-10-29
REL
REL
REL
REL
structures with the lowest energy
20
20
2D 1H-15N HSQC
3D CBCA(CO)NH
3D HNCA
3D HCCH-TOCSY
3D 1H-15N NOESY
3D 1H-13C NOESY aliphatic
1.0
mM
[U-99% 13C; U-99% 15N]
1.0
mM
100
mM
10
mM
0.2
mM
6.0
ambient
298
K
DGSA-distance geometry simulated annealing
1
lowest energy
1.0 mM [U-99% 13C; U-99% 15N] protein_1, 1.0 mM protein_2, 100 mM potassium chloride, 10 mM calcium chloride, 0.2 mM sodium azide, 90% H2O/10% D2O
90% H2O/10% D2O
Brunger, Adams, Clore, Gros, Nilges and Read
structure solution
CNSSOLVE
Brunger, Adams, Clore, Gros, Nilges and Read
refinement
CNSSOLVE
600
Bruker
DRX
Bruker DRX
ALA
1
n
1
ALA
1
A
ASP
2
n
2
ASP
2
A
GLN
3
n
3
GLN
3
A
LEU
4
n
4
LEU
4
A
THR
5
n
5
THR
5
A
GLU
6
n
6
GLU
6
A
GLU
7
n
7
GLU
7
A
GLN
8
n
8
GLN
8
A
ILE
9
n
9
ILE
9
A
ALA
10
n
10
ALA
10
A
GLU
11
n
11
GLU
11
A
PHE
12
n
12
PHE
12
A
LYS
13
n
13
LYS
13
A
GLU
14
n
14
GLU
14
A
ALA
15
n
15
ALA
15
A
PHE
16
n
16
PHE
16
A
SER
17
n
17
SER
17
A
LEU
18
n
18
LEU
18
A
PHE
19
n
19
PHE
19
A
ASP
20
n
20
ASP
20
A
LYS
21
n
21
LYS
21
A
ASP
22
n
22
ASP
22
A
GLY
23
n
23
GLY
23
A
ASP
24
n
24
ASP
24
A
GLY
25
n
25
GLY
25
A
THR
26
n
26
THR
26
A
ILE
27
n
27
ILE
27
A
THR
28
n
28
THR
28
A
THR
29
n
29
THR
29
A
LYS
30
n
30
LYS
30
A
GLU
31
n
31
GLU
31
A
LEU
32
n
32
LEU
32
A
GLY
33
n
33
GLY
33
A
THR
34
n
34
THR
34
A
VAL
35
n
35
VAL
35
A
MET
36
n
36
MET
36
A
ARG
37
n
37
ARG
37
A
SER
38
n
38
SER
38
A
LEU
39
n
39
LEU
39
A
GLY
40
n
40
GLY
40
A
GLN
41
n
41
GLN
41
A
ASN
42
n
42
ASN
42
A
PRO
43
n
43
PRO
43
A
THR
44
n
44
THR
44
A
GLU
45
n
45
GLU
45
A
ALA
46
n
46
ALA
46
A
GLU
47
n
47
GLU
47
A
LEU
48
n
48
LEU
48
A
GLN
49
n
49
GLN
49
A
ASP
50
n
50
ASP
50
A
MET
51
n
51
MET
51
A
ILE
52
n
52
ILE
52
A
ASN
53
n
53
ASN
53
A
GLU
54
n
54
GLU
54
A
VAL
55
n
55
VAL
55
A
ASP
56
n
56
ASP
56
A
ALA
57
n
57
ALA
57
A
ASP
58
n
58
ASP
58
A
GLY
59
n
59
GLY
59
A
ASN
60
n
60
ASN
60
A
GLY
61
n
61
GLY
61
A
THR
62
n
62
THR
62
A
ILE
63
n
63
ILE
63
A
ASP
64
n
64
ASP
64
A
PHE
65
n
65
PHE
65
A
PRO
66
n
66
PRO
66
A
GLU
67
n
67
GLU
67
A
PHE
68
n
68
PHE
68
A
LEU
69
n
69
LEU
69
A
THR
70
n
70
THR
70
A
MET
71
n
71
MET
71
A
MET
72
n
72
MET
72
A
ALA
73
n
73
ALA
73
A
ARG
74
n
74
ARG
74
A
LYS
75
n
75
LYS
75
A
MET
76
n
76
MET
76
A
LYS
77
n
77
LYS
77
A
ASP
78
n
78
ASP
78
A
THR
79
n
79
THR
79
A
ASP
80
n
80
ASP
80
A
SER
81
n
81
SER
81
A
GLU
82
n
82
GLU
82
A
GLU
83
n
83
GLU
83
A
GLU
84
n
84
GLU
84
A
ILE
85
n
85
ILE
85
A
ARG
86
n
86
ARG
86
A
GLU
87
n
87
GLU
87
A
ALA
88
n
88
ALA
88
A
PHE
89
n
89
PHE
89
A
ARG
90
n
90
ARG
90
A
VAL
91
n
91
VAL
91
A
PHE
92
n
92
PHE
92
A
ASP
93
n
93
ASP
93
A
LYS
94
n
94
LYS
94
A
ASP
95
n
95
ASP
95
A
GLY
96
n
96
GLY
96
A
ASN
97
n
97
ASN
97
A
GLY
98
n
98
GLY
98
A
TYR
99
n
99
TYR
99
A
ILE
100
n
100
ILE
100
A
SER
101
n
101
SER
101
A
ALA
102
n
102
ALA
102
A
ALA
103
n
103
ALA
103
A
GLU
104
n
104
GLU
104
A
LEU
105
n
105
LEU
105
A
ARG
106
n
106
ARG
106
A
HIS
107
n
107
HIS
107
A
VAL
108
n
108
VAL
108
A
MET
109
n
109
MET
109
A
THR
110
n
110
THR
110
A
ASN
111
n
111
ASN
111
A
LEU
112
n
112
LEU
112
A
GLY
113
n
113
GLY
113
A
GLU
114
n
114
GLU
114
A
LYS
115
n
115
LYS
115
A
LEU
116
n
116
LEU
116
A
THR
117
n
117
THR
117
A
ASP
118
n
118
ASP
118
A
GLU
119
n
119
GLU
119
A
GLU
120
n
120
GLU
120
A
VAL
121
n
121
VAL
121
A
ASP
122
n
122
ASP
122
A
GLU
123
n
123
GLU
123
A
MET
124
n
124
MET
124
A
ILE
125
n
125
ILE
125
A
ARG
126
n
126
ARG
126
A
GLU
127
n
127
GLU
127
A
ALA
128
n
128
ALA
128
A
ASP
129
n
129
ASP
129
A
ILE
130
n
130
ILE
130
A
ASP
131
n
131
ASP
131
A
GLY
132
n
132
GLY
132
A
ASP
133
n
133
ASP
133
A
GLY
134
n
134
GLY
134
A
GLN
135
n
135
GLN
135
A
VAL
136
n
136
VAL
136
A
ASN
137
n
137
ASN
137
A
TYR
138
n
138
TYR
138
A
GLU
139
n
139
GLU
139
A
GLU
140
n
140
GLU
140
A
PHE
141
n
141
PHE
141
A
VAL
142
n
142
VAL
142
A
GLN
143
n
143
GLN
143
A
MET
144
n
144
MET
144
A
MET
145
n
145
MET
145
A
THR
146
n
146
THR
146
A
ALA
147
n
147
ALA
147
A
LYS
148
n
148
LYS
148
A
LYS
149
n
1
LYS
149
B
LYS
150
n
2
LYS
150
B
THR
151
n
3
THR
151
B
PHE
152
n
4
PHE
152
B
LYS
153
n
5
LYS
153
B
GLU
154
n
6
GLU
154
B
VAL
155
n
7
VAL
155
B
ALA
156
n
8
ALA
156
B
ASN
157
n
9
ASN
157
B
ALA
158
n
10
ALA
158
B
VAL
159
n
11
VAL
159
B
LYS
160
n
12
LYS
160
B
ILE
161
n
13
ILE
161
B
SER
162
n
14
SER
162
B
ALA
163
n
15
ALA
163
B
SER
164
n
16
SER
164
B
LEU
165
n
17
LEU
165
B
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
ILE
100
A
N
ILE
100
A
O
VAL
136
A
O
VAL
136
1
A
A
O
H
VAL
MET
121
124
1.58
2
A
A
O
H
ILE
LYS
9
13
1.51
7
A
A
O
H
VAL
MET
121
124
1.55
11
A
A
O
HG21
ASP
VAL
118
121
1.52
14
A
A
O
H
VAL
MET
121
124
1.47
14
A
A
O
HG23
ASP
VAL
118
121
1.59
1
A
ASP
56
36.94
70.00
1
A
THR
79
-149.40
-100.26
1
A
ASP
80
-177.03
104.92
1
A
ASP
122
-43.72
-18.65
1
B
LYS
150
-150.86
-41.71
1
B
THR
151
-153.36
-53.99
2
A
ASP
56
28.45
69.22
2
A
THR
79
56.62
-57.98
2
A
ASP
118
-47.31
-16.67
2
A
ASN
137
-110.00
-165.89
2
B
LYS
150
79.29
50.57
2
B
THR
151
-154.51
-62.09
2
B
PHE
152
-153.88
-31.67
2
B
SER
164
-95.50
31.72
3
A
ASP
2
62.97
126.44
3
A
ASP
56
36.80
70.83
3
A
THR
79
-149.14
-106.14
3
A
ASP
80
-160.27
99.22
3
A
LYS
115
-68.96
-136.46
3
A
LEU
116
-31.46
132.91
3
A
ARG
126
-47.14
-14.95
3
A
ALA
147
-105.22
76.18
3
B
LYS
150
-149.16
-39.84
3
B
THR
151
-157.23
-49.54
4
A
ASP
2
63.62
131.57
4
A
ARG
37
-45.76
-19.76
4
A
GLN
41
-175.35
127.14
4
A
ASN
42
-130.04
-53.21
4
A
ASP
56
35.92
69.82
4
A
THR
79
-147.73
-96.67
4
A
ASP
80
-176.69
105.39
4
A
LYS
115
-54.53
-138.34
4
A
LEU
116
-40.30
166.71
4
A
ASP
118
-40.08
-17.75
4
A
ASP
129
-61.63
93.59
4
B
LYS
150
-156.21
-37.33
5
A
GLU
6
-49.78
-17.48
5
A
THR
79
-142.53
-104.50
5
A
LYS
115
-75.11
-137.01
5
A
LEU
116
-33.95
145.39
5
A
ASP
118
-38.64
-16.85
5
A
ALA
128
-149.46
44.18
5
A
ASP
129
-59.62
103.63
5
A
ALA
147
-104.29
74.43
5
B
THR
151
89.28
-33.29
5
B
PHE
152
-173.88
22.44
6
A
ASP
56
26.31
69.54
6
A
ASP
64
-119.69
-162.06
6
A
THR
79
-157.29
-108.61
6
A
ASP
80
-167.59
101.53
6
A
ALA
147
-103.00
78.46
6
B
LYS
150
-156.07
-36.42
7
A
THR
79
-151.87
-106.99
7
A
ASP
80
-168.64
100.40
7
A
LYS
115
-68.33
-136.51
7
A
LEU
116
-36.58
133.29
7
A
ASP
118
-39.53
-16.50
7
A
ASP
122
-40.58
-19.22
7
B
LYS
150
-150.33
-36.99
8
A
ASP
56
31.67
70.40
8
A
THR
79
-39.55
100.09
8
A
ASP
80
172.18
33.48
8
A
ASN
111
-58.86
-4.31
8
A
ASP
118
-49.10
-17.36
8
A
ASP
129
-67.65
79.23
8
B
LYS
150
-152.82
-37.29
8
B
ALA
163
52.42
14.04
9
A
GLU
6
-48.85
-17.57
9
A
ASP
56
33.97
69.98
9
A
THR
79
-153.17
-111.50
9
A
ASP
80
-160.86
100.05
9
A
LYS
115
-67.17
-136.95
9
A
LEU
116
-32.98
133.32
9
A
ASP
118
-41.05
-17.46
9
B
LYS
150
-156.19
-31.50
10
A
ASP
2
64.00
138.89
10
A
GLU
6
-49.08
-17.47
10
A
ASP
64
-100.75
-161.03
10
A
THR
79
-148.98
-86.27
10
A
ASP
80
-176.38
107.98
10
A
ASP
118
-39.84
-23.32
10
A
ALA
128
-168.42
53.70
10
A
ALA
147
-113.73
78.29
10
B
PHE
152
116.94
-4.70
10
B
LYS
153
-145.54
-30.25
11
A
ASP
64
-89.31
-153.61
11
A
THR
79
-151.28
-106.52
11
A
ASP
80
-172.04
102.44
11
A
LYS
115
-66.34
-135.58
11
A
LEU
116
-29.50
132.69
11
A
ASP
129
-68.11
79.25
11
B
LYS
150
-170.48
26.64
11
B
THR
151
-148.53
-35.98
12
A
GLN
41
-174.94
126.53
12
A
ASN
42
-152.90
-60.79
12
A
ASP
56
23.51
68.94
12
A
THR
79
-148.91
-102.09
12
A
ASP
80
-174.47
103.40
12
A
LYS
115
-72.16
-136.03
12
A
LEU
116
-37.02
153.51
12
A
ASP
118
-40.26
-17.74
12
A
ASP
129
-69.15
94.28
12
B
PHE
152
-142.46
10.11
13
A
GLU
6
-48.85
-17.54
13
A
VAL
55
-130.28
-31.34
13
A
ASP
56
45.86
71.67
13
A
ASP
78
-89.29
30.44
13
A
THR
79
-148.74
-34.70
13
A
ASP
80
81.71
111.12
13
A
LYS
115
-67.75
-136.78
13
A
ASP
118
-39.95
-16.63
13
A
ALA
147
-105.83
79.88
13
B
THR
151
-142.80
-39.21
14
A
GLU
6
-49.81
-17.86
14
A
ASP
56
30.78
69.39
14
A
ASP
64
-109.69
-165.25
14
A
THR
79
-148.80
-101.56
14
A
ASP
80
-176.16
105.64
14
A
LYS
115
-67.60
-136.65
14
A
LEU
116
-38.40
132.81
14
A
ASP
122
-41.83
-19.82
14
B
LYS
150
-151.81
-44.59
14
B
THR
151
-141.81
-44.64
15
A
GLU
6
-48.97
-17.69
15
A
ASP
56
32.51
69.44
15
A
THR
79
-149.66
-102.54
15
A
ASP
80
-174.01
105.32
15
A
ASP
122
-48.89
-18.13
15
A
ASP
129
-67.37
87.55
15
A
ALA
147
-90.23
48.86
15
B
LYS
150
-159.36
18.30
15
B
THR
151
-152.51
-45.17
16
A
GLU
6
-49.47
-17.48
16
A
ASP
56
30.24
68.00
16
A
ASP
64
-103.35
-161.74
16
A
THR
79
-152.86
-111.63
16
A
ASP
80
-162.78
100.60
16
A
ASP
122
-44.75
-18.57
16
A
ASP
129
-69.42
85.46
16
B
LYS
150
-151.89
-34.49
17
A
ASP
56
23.05
69.22
17
A
THR
79
-149.38
-111.71
17
A
ASP
80
-179.72
105.51
17
A
LYS
115
-70.39
-135.51
17
A
LEU
116
-27.97
133.40
17
A
ASP
118
-37.87
-20.70
17
A
ASP
129
-65.98
98.46
17
A
ALA
147
-94.47
30.29
17
B
LYS
150
-163.13
-36.21
18
A
GLU
6
-49.51
-17.67
18
A
THR
79
-152.42
-114.15
18
A
LYS
115
-66.96
-136.49
18
A
LEU
116
-33.78
132.58
18
A
ASP
118
-44.50
-17.21
18
B
LYS
150
79.88
-10.61
19
A
GLU
6
-48.50
-17.63
19
A
THR
79
-151.10
-110.77
19
A
ASP
80
-163.85
100.99
19
A
LYS
115
-66.62
-136.64
19
A
ASP
122
-41.15
-17.65
19
A
ASN
137
-114.87
-164.84
19
B
LYS
150
-141.96
-59.44
19
B
THR
151
-154.16
-31.37
20
A
GLU
6
-49.80
-17.24
20
A
ASP
56
34.36
69.93
20
A
THR
79
-150.26
-107.73
20
A
ASP
93
-56.07
100.81
20
A
LYS
115
-72.41
-135.81
20
A
LEU
116
-28.04
132.91
20
A
ASP
118
-36.97
-19.03
20
A
ASP
122
-48.05
-17.87
20
A
ALA
128
-153.07
42.52
20
B
LYS
150
-169.35
-30.33
lowest energy, model 1
Solution NMR structure of CaM bound to the eNOS CaM binding domain peptide
1
N
N
2
N
N
A
THR
5
A
THR
5
HELX_P
A
GLU
14
A
GLU
14
1
1
10
A
ALA
15
A
ALA
15
HELX_P
A
ASP
20
A
ASP
20
1
2
6
A
GLU
31
A
GLU
31
HELX_P
A
GLY
40
A
GLY
40
1
3
10
A
THR
44
A
THR
44
HELX_P
A
ASP
50
A
ASP
50
1
4
7
A
ASP
64
A
ASP
64
HELX_P
A
LEU
69
A
LEU
69
1
5
6
A
LEU
69
A
LEU
69
HELX_P
A
ARG
74
A
ARG
74
1
6
6
A
SER
81
A
SER
81
HELX_P
A
ARG
86
A
ARG
86
1
7
6
A
ARG
86
A
ARG
86
HELX_P
A
ASP
93
A
ASP
93
1
8
8
A
ALA
102
A
ALA
102
HELX_P
A
THR
110
A
THR
110
1
9
9
A
ASN
111
A
ASN
111
HELX_P
A
GLY
113
A
GLY
113
5
10
3
A
GLU
119
A
GLU
119
HELX_P
A
ALA
128
A
ALA
128
5
11
10
A
ASN
137
A
ASN
137
HELX_P
A
MET
145
A
MET
145
1
12
9
B
PHE
152
B
PHE
4
HELX_P
B
SER
162
B
SER
14
1
13
11
OXIDOREDUCTASE
OXIDOREDUCTASE
CALM_HUMAN
UNP
1
2
P62158
ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTD
SEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK
NOS3_HUMAN
UNP
2
493
P29474
KKTFKEVANAVKISASL
2
149
2LL7
1
148
P62158
A
1
1
148
493
509
2LL7
149
165
P29474
B
2
1
17
2
anti-parallel
A
ILE
100
A
ILE
100
A
SER
101
A
SER
101
A
GLN
135
A
GLN
135
A
VAL
136
A
VAL
136